, Tracking Stock Market Picks
Enter Symbol:
Ziopharm Oncology Inc (ZIOP) [hlAlert]

up 157.27 %

Ziopharm Oncology Inc (ZIOP) rated Buy

Posted on: Thursday,  Oct 11, 2007  9:25 AM ET by Oppenheimer

Oppenheimer rated Buy Ziopharm Oncology Inc (NASDAQ: ZIOP) on 10/11/2007, when the stock price was $3.37. Since
then, Ziopharm Oncology Inc has gained 157.27% as of 09/11/2015's recent price of $8.67.
If you would have followed this Oppenheimer's recommendation on ZIOP, you would have gained 157.27% of your investment in 2892 days.

ZIOPHARM Oncology, Inc. (ZIOPHARM) is a development-stage biopharmaceutical company. The Company focuses on developing and commercializing a portfolio of in-licensed cancer drugs that address unmet medical needs. The Company is focused on licensing and developing drug candidate families that are related to cancer therapeutics already on the market or in development and that can be developed in intravenous (IV) and/or oral forms of administration. As of December 31, 2008, it was in Phase I and Phase I/II studies for three product candidates known as darinaparsin (Zinapar ZIO-101), palifosfamide (Zymafos ZIO-201) and indibulin ( Zybulin ZIO-301).

OppenheimerFunds, Inc. has been helping investors achieve their financial goals since 1960. We are one of the nation's largest and most respected asset management companies. At OppenheimerFunds, we believe that in order for you to reach your financial goals, your investments must perform. That is why investment excellence—over the long term and across the range of our products—is our highest priority. OppenheimerFunds and its controlled affiliates offer a broad range of products and services to individuals, corporations and institutions, including mutual funds, separately managed accounts, investment management for institutions, hedge fund products, qualified retirement plans and subadvisory investment-management services.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
10/11/2007 9:25 AM Buy
3.37 10.00
as of 8/27/2015
1 Week down  -28.93 %
1 Month down  -26.46 %
3 Months down  -7.17 %
1 YTD up  99.76 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy